Supervisor Database Search
Guidance for ICAT Supervisors
The ICAT Supervisor list is reviewed annually by the partner universities and updated online in March/April each year.
You can read about the ICAT supervisor selection process and eligibility criteria below:
Terms of reference/guide to supervising ICAT Fellows.
You can read the terms of reference for supervisors actively supervising ICAT Fellows below:
Supervisor Database
Search for supervisors below. You can filter your search using the options and select multiple fields by holding CTRL (Cmd on Mac) + clicking multiple options in a list.
Full NameProfessor Noemi Lois
Wellcome-Wolfson Institute for Experimental Medicine
Queen's University Belfast
Webpage:qub.ac.uk
Email hidden; Javascript is required.
- cell and developmental biology/regenerative medicine
- clinical trials
- Other
Ophthalmology
- Ophthalmology
Prof. Lois leads a programme of preclinical and clinical research into diabetic retinopathy and its complications, namely diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR). This research extends from pathogenic mechanisms of disease and risk stratification to new therapies, including determining the most cost-effective therapeutic alternatives for this disease.
Prof. Lois is PI of two large multicentric NIHR-funded clinical studies, DIAMONDS and EMERALD. DIAMONDS is evaluating the clinical- and cost-effectiveness of diode subthreshold micropulse laser for the treatment of patients with mild (central retinal subfield thickness of less than 400 microns) DMO. EMERALD is evaluating a new alternative approach for the surveillance of patients with previously treated and inactive DMO and PDR which involves multimodal imaging and review of patients by trained ophthalmic photographers/imaging technicians.
Prof. Lois is also currently leading a phase-2 clinical trial evaluating a new potential treatment for DMO, ARA290.